85 related articles for article (PubMed ID: 18030870)
1. [Assessment of plasminogen activator inhibitor-1 and von Willebrand factor as a markers of endothelial function in patients with end-stage kidney disease after allotransplantation during a one-year follow-up].
Doroszewski W; Włodarczyk Z; Strózecki P; Manitius J; Grabarczyk E; Rość D; Odrowaz-Sypniewska G
Pol Arch Med Wewn; 2007; 117(5-6):213-20. PubMed ID: 18030870
[TBL] [Abstract][Full Text] [Related]
2. Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity.
Stam F; van Guldener C; Schalkwijk CG; ter Wee PM; Donker AJ; Stehouwer CD
Nephrol Dial Transplant; 2003 May; 18(5):892-8. PubMed ID: 12686661
[TBL] [Abstract][Full Text] [Related]
3. Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease.
Pannier B; Guerin AP; Marchais SJ; Metivier F; Safar ME; London GM
Kidney Int; 2000 Mar; 57(3):1091-9. PubMed ID: 10720961
[TBL] [Abstract][Full Text] [Related]
4. Endothelial cell markers (vWF, t-PA and PAI-1) in the elderly.
Gaussem P; Levy C; Verny M; Anglés-Cano E
Thromb Haemost; 1994 Jul; 72(1):164-5. PubMed ID: 7974369
[No Abstract] [Full Text] [Related]
5. The effect of homocysteine reduction by B-vitamin supplementation on markers of endothelial dysfunction.
Peeters AC; van der Molen EF; Blom HJ; den Heijer M
Thromb Haemost; 2004 Nov; 92(5):1086-91. PubMed ID: 15543337
[TBL] [Abstract][Full Text] [Related]
6. Increased vascular endothelial cell markers in patients with chronic renal failure on maintenance haemodialysis.
Takagi M; Wada H; Mukai K; Kihira H; Yano S; Minamikawa K; Wakita Y; Nakase T; Nagaya S; Deguchi K
Blood Coagul Fibrinolysis; 1994 Oct; 5(5):713-7. PubMed ID: 7865676
[TBL] [Abstract][Full Text] [Related]
7. Endothelial marker proteins in hyperhomocysteinemia.
de Jong SC; Stehouwer CD; van den Berg M; Vischer UM; Rauwerda JA; Emeis JJ
Thromb Haemost; 1997 Nov; 78(5):1332-7. PubMed ID: 9408014
[TBL] [Abstract][Full Text] [Related]
8. Advanced glycation end-product peptides are associated with impaired renal function, but not with biochemical markers of endothelial dysfunction and inflammation, in non-diabetic individuals.
Stam F; Schalkwijk CG; van Guldener C; ter Wee PM; Stehouwer CD
Nephrol Dial Transplant; 2006 Mar; 21(3):677-82. PubMed ID: 16330467
[TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes: assessment of endothelial lesion and fibrinolytic system markers.
Soares AL; Sousa Mde O; Dusse LM; Fernandes AP; Lasmar MC; Novelli BA; Lages Gde F; Carvalho Md
Blood Coagul Fibrinolysis; 2007 Jul; 18(5):395-9. PubMed ID: 17581312
[TBL] [Abstract][Full Text] [Related]
10. Chronic kidney disease is still present after renal transplantation with excellent function.
Bertoni E; Rosati A; Larti A; Merciai C; Zanazzi M; Rosso G; Gallo M; Marcucci R; Salvadori M
Transplant Proc; 2006 May; 38(4):1024-5. PubMed ID: 16757252
[TBL] [Abstract][Full Text] [Related]
11. The fibrinolytic system in chronic renal failure.
Lottermoser K; Petras S; Pöge U; Fimmers R; Hertfelder HJ; Schiermeyer B; Vetter H; Düsing R
Eur J Med Res; 2001 Sep; 6(9):372-6. PubMed ID: 11591527
[TBL] [Abstract][Full Text] [Related]
12. Plasma homocysteine is weakly correlated with plasma endothelin and von Willebrand factor but not with endothelium-dependent vasodilatation in healthy postmenopausal women.
de Valk-de Roo GW; Stehouwer CD; Lambert J; Schalkwijk CG; van der Mooren MJ; Kluft C; Netelenbos C
Clin Chem; 1999 Aug; 45(8 Pt 1):1200-5. PubMed ID: 10430785
[TBL] [Abstract][Full Text] [Related]
13. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis.
Blann AD; Dobrotova M; Kubisz P; McCollum CN
Thromb Haemost; 1995 Aug; 74(2):626-30. PubMed ID: 8584997
[TBL] [Abstract][Full Text] [Related]
14. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Cugno M; Mari D; Meroni PL; Gronda E; Vicari F; Frigerio M; Coppola R; Bottasso B; Borghi MO; Gregorini L
Br J Haematol; 2004 Jul; 126(1):85-92. PubMed ID: 15198737
[TBL] [Abstract][Full Text] [Related]
15. Raynaud's phenomenon and endothelial dysfunction in end-stage renal disease patients treated with hemodialysis.
Czupryniak A; Kałuzyńska A; Nowicki M; Wiecek B; Bald E; Owczarek D
Kidney Blood Press Res; 2005; 28(1):27-31. PubMed ID: 15452382
[TBL] [Abstract][Full Text] [Related]
16. Unfractionated heparin but not enoxaparin causes delayed plasma PAI-1 depletion in hemodialysis patients: a prospective study.
Naumnik B; Pawlak K; Mys'liwiec M
Clin Appl Thromb Hemost; 2009 Feb; 15(1):84-91. PubMed ID: 17895513
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell activation in cutaneous vasculitis.
Jurd KM; Stephens CJ; Black MM; Hunt BJ
Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
[TBL] [Abstract][Full Text] [Related]
18. Improved fibrinolysis after one year of treatment with enalapril in men and women with uncomplicated myocardial infarction.
Boman KO; Jansson JH; Nyhlén KA; Nilsson TK
Thromb Haemost; 2002 Feb; 87(2):311-6. PubMed ID: 11859853
[TBL] [Abstract][Full Text] [Related]
19. Serum total homocysteine concentration before and after renal transplantation.
Arnadottir M; Hultberg B; Wahlberg J; Fellström B; Dimény E
Kidney Int; 1998 Oct; 54(4):1380-4. PubMed ID: 9767559
[TBL] [Abstract][Full Text] [Related]
20. Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure.
Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
Adv Med Sci; 2008; 53(1):32-6. PubMed ID: 18635422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
